Innovation in cell therapy for cancer is at an all-time high, with the exploration of autologous and allogeneic therapies derived from T cells, NK cells, macrophages and beyond.

    What are the latest developments, and how are challenges in R&D, manufacturing, logistics and market access being tackled?

    Discover from our experts the solutions to your biggest challenges and gain answers to your most pressing questions including:

    • What clinical progress has been achieved in allogeneic therapies
    • Whether CAR-T has a future in solid tumors
    • How genetic engineering can enhance the efficacy of cell therapies in the tumor microenvironment
    • How to scale up manufacturing for clinical and commercial production
    • How to ensure patient access to these life-changing drugs

    Interested to find out what else will be explored at OCTS, and who will be joining us from other industry-leading companies such as BMS, Novartis, Kite, Adicet, Intellia, In8bio and more? Get the agenda: https://hubs.ly/Q013-9Kd0

    Event Name: The Onco Cell Therapy Summit
    Event Venue: Boston, USA
    Event Date: June 29-30 2022
    Event website link: https://oncocelltherapy.com/events/octs-usa
    Event Organizer Name: Kisaco Research
    Communication number (with country & area code): +44 (0)20 3696 2920
    Email ID: laura.hobson@kisacoresearch.com
    Social Media Link’s: https://www.linkedin.com/showcase/oncocelltherapyseries https://twitter.com/kr_octs

    Organiser: Kisaco Research

    Kisaco Research works with the early adopters and leaders of growth markets in driving their respective industries forward and in providing the right knowledge, learning and social opportunities to stimulate business growth quickly and effectively.

    Kisaco Research produces, designs and hosts B2B industry conferences and exhibitions. Our platforms are neutral, so that our attendees get the right information from the most relevant people.